Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine

British Journal of Pharmacology
M J DalyR Stables

Abstract

1 Ranitidine has been investigated as an antagonist of the H2-receptor-mediated responses to histamine of guniea-pig atrium and rat uterus in vitro and as an inhibitor of gastric acid secretion in the rat. 2 Ranitidine competitively antagonized histamine-induced increases in contraction frequency of the guinea-pig isolated rat atrium. Ranitidine had a pA2 of 7.2 and was 7.9 and 4.5 times more potent than metiamide and cimetidine respectively. 3 Ranitidine competitively antagonized histamine-induced relaxations of the rat isolated uterine horn. Ranitidine had a pA2 of 6.95 and was 3.6 and 5.9 times more potent than metiamide and cimetidine respectively. 4 Ranitidine, even at high concentrations, did not affect responses of the guinea-pig isolated atrium or rat isolated uterus to (-)-isoprenaline. Similarly it was without effect on either histamine or bethanechol-induced contractions of guinea-pig isolated ileum. 5 Ranitidine inhibited histamine- and pentagastrin-induced gastric acid secretion in the perfused stomach preparation of the anaesthetized rat. Ranitidine was 5.2 and 7.0 times more potent on a molar basis than metiamide and cimetidine respectively, as an inhibitor of histamine-induced gastric acid secretion. 6 It is con...Continue Reading

References

Aug 1, 1977·The Journal of Clinical Endocrinology and Metabolism·H E Carlson, A F Ippoliti
Feb 15, 1975·Lancet·J A ForrestL R Celestin
Jun 18, 1977·Lancet·G F Delle FaveA Torsoli
Jan 1, 1977·General Pharmacology·D A Owen
Feb 1, 1979·The Journal of Clinical Endocrinology and Metabolism·J W Funder, J E Mercer
Oct 1, 1973·Agents and Actions·J W BlackJ H Wyllie
Aug 1, 1966·British Journal of Pharmacology and Chemotherapy·A S Ash, H O Schild
Apr 21, 1972·Nature·J W BlackE M Parsons
Mar 1, 1958·British Journal of Pharmacology and Chemotherapy·M N GHOSH, H O SCHILD
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Oct 1, 1947·Physiological Reviews·E R LOEW

❮ Previous
Next ❯

Citations

Oct 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·A O Donoso, M Barontini
Jan 1, 1996·Journal of Neural Transmission·E O Alvarez, A M Banzan
Dec 1, 1991·Digestive Diseases and Sciences·J P HakkinenL A Reiter
Apr 1, 1982·Agents and Actions·G Bertaccini, G Coruzzi
Feb 1, 1987·Agents and Actions·L CandussioL Baldini
Mar 25, 1983·European Journal of Pharmacology·J A Smith
Aug 5, 1983·European Journal of Pharmacology·M TakedaH Maeno
Oct 6, 1987·European Journal of Pharmacology·R RubinsteinS Cohen
Feb 15, 1996·European Journal of Pharmacology·T IchikawaK Hotta
Jan 1, 1984·Pharmacology & Therapeutics·R E Pounder
Apr 24, 1990·Regulatory Peptides·R HåkansonJ Axelson
Jul 1, 1994·General Pharmacology·G KounenisV Elezoglou
Mar 21, 1998·General Pharmacology·B PalaciosL San Román
Aug 31, 1999·Journal of Autonomic Pharmacology·A VelascoJ García del Pozo
Dec 1, 1991·British Journal of Pharmacology·N J HaywardG N Woodruff
Dec 1, 1996·Gut·A GarnerM E Parsons
Jan 1, 1990·European Journal of Clinical Pharmacology·E C MeyerJ C Avenant
Dec 4, 1982·Lancet·D JackD A Richards
May 4, 2013·British Journal of Pharmacology·M GschwandtnerR Gutzmer
May 1, 1985·British Journal of Clinical Pharmacology·J M HughesD M Temple
Mar 1, 1983·Journal of Clinical and Hospital Pharmacy·J DawsonR Cockel
Aug 1, 1984·British Journal of Clinical Pharmacology·N TheofilopoulosC M Bradshaw
Mar 1, 1984·Journal of Autonomic Pharmacology·H C Cheng, J K Woodward
Jan 1, 1982·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S RendićH H Ruf
Jul 1, 1982·Agents and Actions·T J Rising, S Lewis
Nov 1, 1985·British Journal of Pharmacology·J W BlackN P Shankley
Dec 1, 1983·Drug Intelligence & Clinical Pharmacy·T S Gaginella, J H Bauman
Jul 27, 1999·British Journal of Clinical Pharmacology·M GrossmannW Kirch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.